Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells
Marco Donia(University of Copenhagen), Ferdinando Nicoletti(University of Catania), Paolo Fagone(University of Catania), Vincenzo Perciavalle(University of Catania), Katia Mangano(University of Catania), Sanja Mijatović(University of Belgrade), Rocco De Pasquale(Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele), Stanislava Stošić‐Grujičić(Institute for Biological Research “Siniša Stanković”), Giuseppe A. G. Lombardo(University of Catania), Yousef Al‐Abed(Feinstein Institute for Medical Research), Danijela Maksimović‐Ivanić(Institute for Biological Research “Siniša Stanković”), Julio Rodríguez Padrón(Tethys Research Institute), Marinella Coco(University of Catania), Franco Dinotta(University of Catania), Mai-Britt Zocca(Northwell Health)
Cited by 23
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495